- Home
- LGCB vs SILO Comparison
LGCB vs SILO Comparison
Compare LGCB & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- SILO
- Stock Information
- Founded
- LGCB 2011
- SILO 2010
- Country
- LGCB Japan
- SILO United States
- Employees
- LGCB N/A
- SILO N/A
- Industry
- LGCB
- SILO Apparel
- Sector
- LGCB
- SILO Consumer Discretionary
- Exchange
- LGCB Nasdaq
- SILO Nasdaq
- Market Cap
- LGCB 8.4M
- SILO 8.8M
- IPO Year
- LGCB 2023
- SILO N/A
- Fundamental
- Price
- LGCB $1.97
- SILO $1.14
- Analyst Decision
- LGCB
- SILO
- Analyst Count
- LGCB 0
- SILO 0
- Target Price
- LGCB N/A
- SILO N/A
- AVG Volume (30 Days)
- LGCB 1.1M
- SILO 37.6K
- Earning Date
- LGCB 05-06-2025
- SILO 05-12-2025
- Dividend Yield
- LGCB N/A
- SILO N/A
- EPS Growth
- LGCB N/A
- SILO N/A
- EPS
- LGCB N/A
- SILO N/A
- Revenue
- LGCB $10,289,681.00
- SILO $72,102.00
- Revenue This Year
- LGCB N/A
- SILO $1.86
- Revenue Next Year
- LGCB N/A
- SILO N/A
- P/E Ratio
- LGCB N/A
- SILO N/A
- Revenue Growth
- LGCB N/A
- SILO N/A
- 52 Week Low
- LGCB $1.22
- SILO $0.77
- 52 Week High
- LGCB $57.05
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- LGCB 53.20
- SILO 48.18
- Support Level
- LGCB $1.68
- SILO $0.99
- Resistance Level
- LGCB $2.07
- SILO $1.19
- Average True Range (ATR)
- LGCB 0.36
- SILO 0.08
- MACD
- LGCB 0.04
- SILO 0.02
- Stochastic Oscillator
- LGCB 63.56
- SILO 79.17
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.